Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can jeopardize their other revenue-generating business lines like M&A advisory.

At StockStory, we look beyond the headlines with our independent analysis to determine whether these bearish calls are justified. Keeping that in mind, here are two stocks poised to prove Wall Street wrong and one where the outlook is warranted.

One Stock to Sell:

Steven Madden (SHOO)

Consensus Price Target: $32.50 (-6.2% implied return)

As seen in the infamous Wolf of Wall Street movie, Steven Madden (NASDAQ: SHOO) is a fashion brand famous for its trendy and innovative footwear, appealing to a young and style-conscious audience.

Why Does SHOO Fall Short?

1. Lackluster 9.4% annual revenue growth over the last two years indicates the company is losing ground to competitors
2. Lacking free cash flow generation means it has few chances to reinvest for growth, repurchase shares, or distribute capital
3. Eroding returns on capital suggest its historical profit centers are aging

Steven Madden is trading at $34.63 per share, or 21.6x forward P/E. Check out our free in-depth research report to learn more about why SHOO doesn’t pass our bar.

Two Stocks to Watch:

Doximity (DOCS)

Consensus Price Target: $70.11 (4.6% implied return)

With over 80% of U.S. physicians as members of its digital community, Doximity (NYSE: DOCS) operates a digital platform that enables physicians and other healthcare professionals to collaborate, stay current with medical news, manage their careers, and conduct virtual patient visits.

Why Should You Buy DOCS?

1. Average billings growth of 19.8% over the last year enhances its liquidity and shows there is steady demand for its products
2. Fast payback periods on sales and marketing expenses allow the company to invest heavily and onboard many customers concurrently
3. Impressive free cash flow profitability enables the company to fund new investments or reward investors with share buybacks/dividends

At $67 per share, Doximity trades at 21x forward price-to-sales. Is now the time to initiate a position? Find out in our full research report, it’s free for active Edge members.

Curtiss-Wright (CW)

Consensus Price Target: $541.67 (-1.7% implied return)

Formed from a merger of 12 companies, Curtiss-Wright (NYSE: CW) provides a range of products and services to the aerospace, industrial, electronic, and maritime industries.

Why Should CW Be on Your Watchlist?

1. Offerings and unique value proposition resonate with customers, as seen in its above-market 10.2% annual sales growth over the last two years
2. Healthy operating margin of 16.3% shows it’s a well-run company with efficient processes, and its rise over the last five years was fueled by some leverage on its fixed costs
3. Share repurchases over the last two years enabled its annual earnings per share growth of 19.1% to outpace its revenue gains

Curtiss-Wright’s stock price of $550.80 implies a valuation ratio of 41.3x forward P/E. Is now the right time to buy? See for yourself in our in-depth research report, it’s free for active Edge members.

Stocks We Like Even More

Trump’s April 2025 tariff bombshell triggered a massive market selloff, but stocks have since staged an impressive recovery, leaving those who panic sold on the sidelines.

Take advantage of the rebound by checking out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.